This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jul 1;137(26):3581-3582.

doi: 10.1182/blood.2021011572.

Brentuximab vedotin: frontline help in ALCL

G A Amos Burke

PMID: 34196680
DOI: 10.1182/blood.2021011572

Free article

Comment

Brentuximab vedotin: frontline help in ALCL

G A Amos Burke. Blood. 2021.

Free article

. 2021 Jul 1;137(26):3581-3582.

doi: 10.1182/blood.2021011572.

Author

G A Amos Burke

PMID: 34196680
DOI: 10.1182/blood.2021011572

No abstract available

PubMed Disclaimer

Comment on

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1.
Lowe EJ, Reilly AF, Lim MS, Gross TG, Saguilig L, Barkauskas DA, Wu R, Alexander S, Bollard CM. Lowe EJ, et al. Blood. 2021 Jul 1;137(26):3595-3603. doi: 10.1182/blood.2020009806. Blood. 2021. PMID: 33684925 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Brentuximab vedotin: frontline help in ALCL

Brentuximab vedotin: frontline help in ALCL

Author

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources